AllNewsPhotosVideos
The Annotated C++ Reference Manual

Subject Expert Committee

Subject expert committee, Latest News

NTAGI recommends vaccination for Typhoid and Cervical cancer: Sources - Hindi News | NTAGI recommends vaccination for Typhoid and Cervical cancer: Sources | Latest national News at Lokmatnews.in

National :NTAGI recommends vaccination for Typhoid and Cervical cancer: Sources

The National Technical Advisory Group on Immunisation (NTAGI) reviewed the data and recommended the vaccination for Typhoid and Cervical Cancer, said sources on Tuesday. ...

Restricted emergency use approvals to Covishield, Covaxin not granted in haste: SC - Hindi News | Restricted emergency use approvals to Covishield, Covaxin not granted in haste: SC | Latest health News at Lokmatnews.in

Health :Restricted emergency use approvals to Covishield, Covaxin not granted in haste: SC

New Delhi, May 2 The Supreme Court on Monday said the material provided by the Centre does not ... ...

DCGI grants EUA to 3 Covid vaccines for different age group of children - Hindi News | DCGI grants EUA to 3 Covid vaccines for different age group of children | Latest health News at Lokmatnews.in

Health :DCGI grants EUA to 3 Covid vaccines for different age group of children

New Delhi, April 26 The Drugs Controller General of India (DCGI) on Tuesday approved three Covid vaccines for ... ...

Bharat Biotech asked to provide more data on COVID-19 vaccine Covaxin for below 12-year-olds - Hindi News | Bharat Biotech asked to provide more data on COVID-19 vaccine Covaxin for below 12-year-olds | Latest national News at Lokmatnews.in

National :Bharat Biotech asked to provide more data on COVID-19 vaccine Covaxin for below 12-year-olds

The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its COVID-19 vaccine, Covaxin, for administering it to children aged between 2-12 years, sources said. ...

Biological E seeks EUA for COVID vaccine Corbevax for children in 5-12 age group: Official sources - Hindi News | Biological E seeks EUA for COVID vaccine Corbevax for children in 5-12 age group: Official sources | Latest national News at Lokmatnews.in

National :Biological E seeks EUA for COVID vaccine Corbevax for children in 5-12 age group: Official sources

Hyderabad-based pharmaceutical company Biological E has applied for Emergency Use Authorisation (EUA) for its COVID-19 vaccine Corbevax for the 5-12 year age group, official sources said on Wednesday. ...

Over 3 crore beneficiaries in 15-18 age group fully vaccinated against COVID-19 - Hindi News | Over 3 crore beneficiaries in 15-18 age group fully vaccinated against COVID-19 | Latest national News at Lokmatnews.in

National :Over 3 crore beneficiaries in 15-18 age group fully vaccinated against COVID-19

India has achieved a new milestone in its COVID-19 vaccination drive as more than 3 crore youngsters between 15-18 of age group are now fully vaccinated against COVID-19 in the country, said Union Health Minister Mansukh Mandaviya on Saturday. ...

Over 3 crore beneficiaries in 15-18 age group fully vaccinated against COVID-19 - Hindi News | Over 3 crore beneficiaries in 15-18 age group fully vaccinated against COVID-19 | Latest national News at Lokmatnews.in

National :Over 3 crore beneficiaries in 15-18 age group fully vaccinated against COVID-19

India has achieved a new milestone in its COVID-19 vaccination drive as more than 3 crore youngsters between 15-18 of age group are now fully vaccinated against COVID-19 in the country, said Union Health Minister Mansukh Mandaviya on Saturday. ...

DCGI's SEC to review applications of Bharat Biotech, SII for full market approval to Covaxin, Covishield today: Sources - Hindi News | DCGI's SEC to review applications of Bharat Biotech, SII for full market approval to Covaxin, Covishield today: Sources | Latest national News at Lokmatnews.in

National :DCGI's SEC to review applications of Bharat Biotech, SII for full market approval to Covaxin, Covishield today: Sources

Drugs Controller General of India (DCGI)'s Subject Expert Committee will review applications of Bharat Biotech and Serum Institute of India (SII) for full market approval to Covaxin and Covishield respectively on Friday, sources said. ...